Attas DNA
DNA-focused company developing technology and services around genetic analysis.
Company Overview
Snapshot
Founded in April 2025, Attas DNA operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on R&D for its genetic analysis technology.
Business overview
Attas DNA is a Health Tech & Life Sciences company specializing in technology-led capabilities for genetic analysis. The company's core focus is on developing innovative solutions within the DNA and genetics domain, indicating a scalable and innovation-driven approach. While the exact product scope, such as diagnostics, screening, or research, requires further public disclosure, Attas DNA positions itself within the Pharma & Medical Biotechnology sector, specifically targeting Test Diagnostics & Screening.
Log in to access full profile ›Company Intelligence Q&A
- What is Attas DNA's primary focus?
- Attas DNA is focused on developing technology and services around genetic analysis within the Health Tech & Life Sciences sector.
- When was Attas DNA founded?
- Attas DNA was founded in April 2025.
- What is Attas DNA's current product development stage?
- Attas DNA's product is currently in the Research & Development (R&D) stage, as of July 2026, working on its genetic analysis technology.
- What is Attas DNA's current funding stage?
- Attas DNA is currently in the Pre-Funding stage, as of July 2026, actively seeking initial investment for its genetic analysis technology.
- What market does Attas DNA primarily serve?
- Attas DNA operates within the Health Tech & Life Sciences sector, with a specific focus on Pharma & Medical Biotechnology, including Test Diagnostics & Screening.